The American pharmaceutical company BMS of the first of branch will leave from Russian Federation

The American pharmacological company Bristol-Myers Squibb Co. leaves from Russian Federation, reported Vademecum with reference to the sources close to companies. BMS will transfer the Russian business to the partner in Central Europe and Eastern Europe – the Swiss pharmaceutical companies Swixx BioPharma. Until the end of June, 2022 of BMS will close all researches conducted by it to Russian Federation. To the staff of the Russian division working under the legal person "Bristol Myers Skvibb", suggested to pass to work into Swixx BioPharma and promised to pay compensation. To Russian Federation BMS the Krone which have to conducted researches of medicine for an illness...